GlassScriptPhysician profile
Jason M Dancy
NPI 1982643706
$5,833.85
in general payments reported to CMS, 2019-2025
14 companies · $178 in 2025
The $178 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,889 · 2020: $975 · 2021: $533 · 2022: $378 · 2023: $1,469 · 2024: $412 · 2025: $178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,771 · Travel and Lodging: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,770.88 |
| Travel and Lodging | $287.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,550.76 | 2019-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Stryker Corporation | $875.69 | 2022-2023 | Spinejack |
| Vericel Corporation | $97.81 | 2019-2024 | Maci |
| Abbvie INC. | $83.82 | 2023-2025 | Botox |
| Mimedx Group, INC. | $45.19 | 2024 | |
| Allergan, INC. | $28.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $27.60 | 2022 | |
| Averitas Pharma INC. | $24.96 | 2024 | Qutenza |
| Innovation Technologies INC | $22.45 | 2023 | Irrisept |
| Treace Medical Concepts, INC. | $20.01 | 2023 | |
| Si-Bone, INC. | $15.61 | 2023 | |
| Molnlycke Health Care US, LLC | $15.31 | 2025 | Avance, Mepilex Border Post-Op |
| Bioventus LLC | $14.21 | 2024 | Durolane |
| Pfizer INC. | $12.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Dancy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.